VivoSeq
Other

Medication

0

Pipeline Programs↗

17

Active Trials↗

20

Companies Involved↗

Medication is an early-stage landscape with 0 programs across 20 companies. The most active players are Pfizer, AstraZeneca, GSK.

Intelligence

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

85/100

Attrition Rate

12/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalJohnson & Johnson logo

Johnson & Johnson

0 programs

PreclinicalAstellas logo

Astellas

0 programs

PreclinicalV

Verona Pharma plc

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

174

clinical trials

Completed115 · 66%
Unknown status20 · 11%
Terminated13 · 7%
Recruiting8 · 5%
Withdrawn8 · 5%
Active, not recruiting6 · 3%
Other4 · 2%

Clinical Trials

Trial Activity

174 trials

Cannabidiol Medication Intervention Trial
Recruiting·SSunnybrook Health Sciences Centre·Phase 2·NCT06014424·40 enrolled
Acute Effects of Stimulant Medication in College Students With ADHD
Recruiting·UUniversity of Wyoming·Phase 2·NCT03935646·40 enrolled
Alternation in the Human Microbiome With Commonly Used Topical Medications
Recruiting·UUniversity of California, Davis·Phase 1·NCT03437005·24 enrolled
Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen
Recruiting·UUniversity of Chicago·Phase 4·NCT05512754·200 enrolled
Different Medications to Induce Labor
Recruiting·IIcahn School of Medicine at Mount Sinai·Phase 3·NCT06259097·300 enrolled
Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol
Recruiting·OOctober University for Modern Sciences and Arts·N/A·NCT06288477·44 enrolled
Comparing Antipsychotic Medications in LBD Over Time
Recruiting·TThe University of Texas Health Science Center at San Antonio·Phase 4·NCT05590637·94 enrolled
Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
Recruiting·GGaize·N/A·NCT07389473·50 enrolled
New Vital Pulpotomy Medications in Primary Molars
Active, not recruiting·MMansoura University·N/A·NCT05937100·48 enrolled
Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
Active, not recruiting·Daewoong Pharmaceutical Co. LTD. logoDaewoong Pharmaceutical Co. LTD.·N/A·NCT05411887·2,845 enrolled
Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom
Active, not recruiting·FFlorida International University·Phase 4·NCT05469386·288 enrolled
Understanding How Methadone Treatment During Surgery Affects Pain Levels and the Need for Pain Medications After Surgery
Active, not recruiting·MMemorial Sloan Kettering Cancer Center·Phase 3·NCT05417100·17 enrolled
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
Active, not recruiting·AAnders Fink-Jensen, MD, DMSci·Phase 4·NCT04892199·104 enrolled
The Optimal Long Term Treatment Strategy of Anti-resorptive Medications
Active, not recruiting·NNational Taiwan University Hospital·Phase 4·NCT05091086·60 enrolled
Methadone Dose Monitoring With a Remote Medication Monitor
Not yet recruiting·CCari Health Inc.·N/A·NCT06837571·30 enrolled
Page 1 of 12

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)